Hereditary Peripheral Neuropathies: NGS Testing [A Test in Focus]

Six new next-generation sequencing (NGS) panels for the evaluation of hereditary peripheral neuropathies are now available to the Mayo Clinic practice and Mayo Medical Laboratories clients.

Hereditary peripheral neuropathies are quite varied in their presentations and even more diverse in terms of their specific genetic causes. While they can sometimes be framed in terms of the extent of weakness, sensory involvement, and/or autonomic involvements, it is difficult to discern the appropriate test for many patients.

A comprehensive testing approach with next-generation sequencing has been studied to show greater value in testing, and is therefore recommended.

Videos discussing both the clinical and laboratory perspectives for these tests, as well as additional test information can be found here.


Brent Westra

Brent Westra is a Marketing Segment Manager at Mayo Medical Laboratories. He leads marketing strategies for product management and specialty testing along with new media innovations. Brent has worked at Mayo Clinic since 2011.